News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

Clesrovimab added to NHS dm+d 6.1.0 — RSV protection for high-risk infants

Clesrovimab: a new monoclonal antibody in the dm+d The NHS Business Services Authority has added clesrovimab to the dm+d dictionary (version 6.1.0). This is a monoclonal antibody that targets the respiratory syncytial virus (RSV) F protein and is used for passive immunisation in high-risk infants during RSV season. What is clesrovimab used for? Clesrovimab provides […]